Clinical Trial Update: Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase I study evaluating a 5-fluorouracil–based therapy in combination with hydroxytyrosol for advanced or metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Hydroxytyrosol (hydroxytyrosol)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Advanced or Metastatic CRC | Phase 1 | Status: RECRUITING